• About
  • Blog
  1. Home
  3. Blog
  5. Companies
  7. RHHBY

Roche Holding AG(RHHBY)

Other OTC
Sector: Healthcare | Industry: Drug Manufacturers - General
Roche Holding AG logo

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Latest News & Analysis

Scientist analyzing data in a high-tech lab, representing innovation in pharmaceuticals and diagnostics.
Feb 18, 2025

Roche Advances: FDA Approvals and Key Market Innovations

An intraday update on Roche’s robust FDA approvals, strategic partnerships, and market insights driving growth for RHHBY.

Read more →

Professional-grade financial analysis tools for informed investment decisions.

Product

  • Features
  • Pricing

Resources

  • Blog
  • Knowledge Base
  • Community
  • Market Data

Company

  • About
  • Careers
  • Contact
  • Partners

Legal

  • Privacy
  • Terms
  • License
  • Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.